logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > N-Methyl-4-piperi-dinol CAS 106-52-5

N-Methyl-4-piperi-dinol CAS 106-52-5

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 106-52-5

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Plastic bottles, Plastic buckets

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
106-52-5
Appearance::
Yellow Liquid
Molecular Formula::
C6H13NO
Molecular Weight::
115.17400
EINECS NO::
203-406-8
MDL NO::
MFCD00006500
CAS NO::
106-52-5
Appearance::
Yellow Liquid
Molecular Formula::
C6H13NO
Molecular Weight::
115.17400
EINECS NO::
203-406-8
MDL NO::
MFCD00006500
N-Methyl-4-piperi-dinol CAS 106-52-5

Product Description:

Product Name: N-Methyl-4-piperi-dinol CAS NO: 106-52-5

 

 

Synonyms:

1-methylpiperidin-4-ol;

4-hydroxy-N-methyl piperi-dine;

N-Methylpiperidol;

 

 

Chemical & Physical Properties:

Appearance: Yellow liquid

Assay :≥99.0%

Density: 1.005 g/cm3

Boiling Point: 200℃

Melting Point: 29-31℃

Flash Point: 87℃

Refractive Index: 1.476-1.479

Water Solubility: MISCIBLE

Stability: Stable at room temperature in closed containers under normal storage and handling conditions.

Storage Condition: Keep away from heat, sparks, and flame. Keep away from sources of ignition. Store in a cool, dry, well-ventilated area away from incompatible substances. Do not expose to air. Store protected from moisture. Store under an inert atmosphere.

Vapor Pressure: 0.00834mmHg at 25℃

 

 

Safety Information:

Safety Statements: S26-S37/39

HS Code: 29333999

WGK Germany: 3

Risk Statements: R36/37/38

Hazard Code: Xi

 

 

Reactant for:• ;Optimization of Novobiocin scaffold to product antitumor agents1• ;Substitution about the rigidifying ring for histamine H4 receptor antagonist synthesis2Reactant for synthesis of:• ;CaMKII inhibitors3• ;VEGFR and FGFR kinase inhibitors4• ;Phosphoinositide-3-kinase inhibitors5• ;Protein lysine methyltransferase G9a inhibitors6.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.